Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer

Cell Reports(2022)10.1016/j.celrep.2022.110641Source: DataRank Database

Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)OA: goldTopics (51)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

José Antonio Ortega ORCID,Linh M. Vuong,Isabella Maria Acquistapace ORCID,Stephanie J. Hachey ORCID,Jessica L. Flesher ORCID

Live enrichment

PubMed:35385746

National Cancer Institute

Grant: T32CA009054

National Cancer Institute

Grant: U54CA217378

National Cancer Institute

Grant: R01CA244571

University of California, Irvine

Grant: CA16672

National Institutes of Health

Grant: R50CA221675

Associazione Italiana per la Ricerca sul Cancro

Grant: IG 23679

National Institutes of Health

Grant: 5R01CA244571-02

Identifying Therapeutic Targets for Stage III Melanoma

National Institutes of Health

Grant: 5U54CA217378-05

Complexity, Cooperation and Community in Cancer

National Institutes of Health

Grant: 1S10OD021718-01

High-Throughput DNA Sequencer

National Institutes of Health

Grant: 1S10OD010794-01

PacBio RS Single Molecule, Real-Time (SMRT) DNA Sequencer

National Institutes of Health

Grant: 5R50CA221675-02

Functional Proteomics by Reverse Phase Protein Array in Cancer

National Institutes of Health

Grant: 2T32CA009054-16

CARCINOGENESIS

National Institutes of Health

Grant: 3P30CA062203-27S1

Clinical Trial Advancement and Development for Sarcomas

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 1S10RR025496-01

High Throughput DNA Sequencer

NCI NIH HHS

Grant: R01 CA151513

NCI NIH HHS

Grant: P30 CA016672

NIH HHS

Grant: S10 OD021718

NIAMS NIH HHS

Grant: P30 AR075047

NCRR NIH HHS

Grant: S10 RR025496

NCI NIH HHS

Grant: P30 CA062203

NIH HHS

Grant: S10 OD010794

goldLicense: cc-by

publisherhttp://www.cell.com/article/S221112472200393X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S221112472200393X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S221112472200393X?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9127750

https://doi.org/10.1016/j.celrep.2022.110641

Fields of Study

03 medical and health sciences0302 clinical medicineAnimalsEndothelial CellsHumansMiceNeoplasmsNeovascularization, PathologicSignal TransductionTumor Microenvironmentcdc42 GTP-Binding Proteinrho GTP-Binding Proteins

MeSH Terms

AnimalsEndothelial CellsHumansMiceNeoplasmsNeovascularization, PathologicSignal TransductionTumor Microenvironmentcdc42 GTP-Binding Proteinrho GTP-Binding Proteins

Keywords

rho GTP-Binding Proteins570tumorQH301-705.5Medical Physiology610ArticleangiogenesisMiceNeoplasmsmelanomaTumor Microenvironment2.1 Biological and endogenous factorscancerAnimalsHumansBiology (General)cdc42 GTP-Binding ProteinNeovascularizationPathologicCDC42/RHOJ GTPaseNeovascularization, PathologicEndothelial CellsBiological Sciencesinhibitor5.1 PharmaceuticalsCP: Molecular biologyBiochemistry and Cell BiologySignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health